Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale Sort descending
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Area funzionale Sort descending Data di pubblicazione
Associate Director, Corporate Event Marketing Cambridge (USA) USA Corporate Affairs CTS Communications & Public Affairs Ott 16, 2024
Government Affairs Manager Moscow (City) Fed. Russa Corporate Affairs Innovative Medicines Communications & Public Affairs Lug 29, 2024
Manager, Corporate Marketing Creative & Design East Hanover USA Corporate Affairs CTS Communications & Public Affairs Ott 17, 2024
Director of Global & Swiss Media & Editorial Basel (City) Svizzera Corporate CTS Communications & Public Affairs Ott 18, 2024
Communication & Patient Advocacy Manager (f/m/d) Vienna Austria International CTS Communications & Public Affairs Set 24, 2024
Manager, Post Production & Video Services Hyderabad (Office) India Corporate Affairs CTS Communications & Public Affairs Ott 04, 2024
Lead - Government Affairs Delhi (Office) India International Innovative Medicines Communications & Public Affairs Ott 15, 2024
Comms & Engagement Manager Amsterdam Paesi Bassi Corporate Affairs CTS Communications & Public Affairs Ott 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Svizzera Corporate Affairs CTS Communications & Public Affairs Ott 16, 2024
Manager, Digital Storytelling Remote Position (USA) USA Corporate Affairs CTS Communications & Public Affairs Ott 18, 2024
Vice President of European Public Affairs Vilvoorde Belgio Corporate Affairs Innovative Medicines Communications & Public Affairs Ott 10, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Ott 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Ott 08, 2024
EA & Program Coordinator Beijing (Beijing) Cina Corporate Affairs Innovative Medicines Communications & Public Affairs Set 03, 2024
Public Affairs Manager Ankara Gimat Turchia International Innovative Medicines Communications & Public Affairs Set 13, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Communications & Public Affairs Lug 09, 2024
Patient Engagement Lead İstanbul Kavacık Turchia Corporate Affairs CTS Communications & Public Affairs Set 03, 2024
Executive Director, Public Affairs LaCan Region East Hanover USA Corporate Affairs Corporate Communications & Public Affairs Mag 09, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Tecnologia dell'informazione Ott 18, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Messico Operations CTS Tecnologia dell'informazione Lug 15, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Giappone Operations CTS Tecnologia dell'informazione Lug 22, 2024
GCP Inspection Project Manager London (The Westworks) Regno Unito Development Innovative Medicines Quality Ott 16, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Ott 17, 2024
Lead, QSRC (Quality System Regulatory Compliance) Tuas South Avenue Singapore Operations Innovative Medicines Quality Ott 17, 2024
Ekspert upravljanja kakovosti za proces proizvodnje bioloških učinkovin (m/ž/d) / QA expert for the production process of biological agents (m/f/d) Mengeš Slovenia Operations Innovative Medicines Quality Ott 17, 2024
Quality Assurance Manager - QP/RP Amsterdam Paesi Bassi Operations Innovative Medicines Quality Set 17, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 20, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 23, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud Francia Operations Innovative Medicines Quality Set 03, 2024
Laboratorijski analitik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 17, 2024
Specialist kontrole kakovosti (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 17, 2024
AS&T specialist (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 17, 2024
Digital Quality Control specialist INSURGENTES Messico Operations Innovative Medicines Quality Ott 17, 2024
Compliance & Quality System Manager Ivrea Italia Operations Innovative Medicines Quality Ott 17, 2024
Quality Control Staff Sasayama Giappone Operations Innovative Medicines Quality Ott 18, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Set 24, 2024
Labortechniker / QC Analyst II (m/w/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Set 26, 2024
QC Specialist II (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Set 26, 2024
Vodja skupine kontrole kakovosti v QLS Velike Molekule / Vodja laboratorija Bioanalitika (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Set 27, 2024
QC Specialist II (m/f/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Ott 03, 2024
QA Compliance Expert – Reg CMC Facilitator Schaftenau Austria Operations Innovative Medicines Quality Ott 03, 2024
Specialist upravljanja kakovosti dobaviteljev II (m/ž/d)/ QA supplier management specialist II (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 03, 2024
Senior Quality Manager (m/f/d) Schaftenau Austria Development Innovative Medicines Quality Ott 03, 2024
QC Analyst IV Tuas South Avenue Singapore Operations Innovative Medicines Quality Ott 03, 2024
Sr. Compliance Specialist Morris Plains USA Operations Innovative Medicines Quality Ott 03, 2024
QC Analyst III Tuas South Avenue Singapore Operations Innovative Medicines Quality Ott 03, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Ott 04, 2024
Global GMP Expert Quality Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Ott 07, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Set 30, 2024
AS&T Expert (Micro) Tuas South Avenue Singapore Operations Innovative Medicines Quality Ott 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia